Over the past 12 months, 0 insiders at ACCELERON PHARMA INC filed 0 open-market SEC Form 4 transactions on XLRN: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 27, 21 | Sujay KangoEVP, Chief Commercial Officer | SELL | 5.0K | $175.00 | $875K |
| Sep 24, 21 | Kevin F McLaughlinSVP, CFO and Treasurer | SELL | 5.4K | $160.38 | $861K |
| Sep 23, 21 | Kevin F McLaughlinSVP, CFO and Treasurer | SELL | 18.6K | $161.26 | $3.0M |
| Sep 21, 21 | Sujay KangoEVP, Chief Commercial Officer | SELL | 5.0K | $150.03 | $750K |
| Sep 21, 21 | Adam M VenessSVP, General Counsel and Sec. | SELL | 6.7K | $150.05 | $998K |
| Sep 9, 21 | Adam M VenessSVP, General Counsel and Sec. | SELL | 1.4K | $130.00 | $183K |
| Sep 8, 21 | Adam M VenessSVP, General Counsel and Sec. | SELL | 6 | $130.00 | $780 |
Over the past 12 months, insiders at ACCELERON PHARMA INC filed 0 open-market purchases worth $0 and 0 sales worth $0 on XLRN, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at ACCELERON PHARMA INC filed open-market SEC Form 4 transactions on XLRN over the last 12 months.
InsiderTape plots every XLRN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ACCELERON PHARMA INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →